Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c

The vaccine Mycobacterium bovis Bacillus Calmette-Guérin (BCG) elicits an immune response that is protective against certain forms of tuberculosis (TB); however, because BCG efficacy is limited it is important to identify alternative TB vaccine candidates. Recently, the BCG deletion mutant and vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunasena, Manuja, Shukla, Rajni Kant, Yao, Naiquan, Rosas Mejia, Oscar, Powell, Michael D., Oestreich, Kenneth J., Aceves-Sánchez, Michel de Jesús, Flores-Valdez, Mario Alberto, Liyanage, Namal P. M., Robinson, Richard T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300728/
https://www.ncbi.nlm.nih.gov/pubmed/35858977
http://dx.doi.org/10.1038/s41598-022-14935-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300728/
https://www.ncbi.nlm.nih.gov/pubmed/35858977
http://dx.doi.org/10.1038/s41598-022-14935-y

Ejemplares similares